Success Story: A Pharmacology & Toxicology Researcher's Journey from Bangladesh to NIW Success without RFE
Client’s Testimonial:
“Thank you very much for all of your hard work and smart move to make my I-140 submission successful.”
On February 18th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Pharmacology & Toxicology (Approval Notice).
General Field: Pharmacology & Toxicology
Position: Postdoctoral Researcher
Country of Origin: Bangladesh
State of Residence at the Time of Filing: Maryland
Approval Notice Date: February 18th, 2026
Processing Time: 17 months, 19 days
Case Summary:
It was a privilege for our team to assist a postdoctoral researcher from Bangladesh, who holds a Ph.D. in the complexity of life, with their EB-2 NIW petition. In line with our commitment to I-140 clients, we adopted a strategic, case-by-case approach, carefully analyzing the client's qualifications to craft a compelling and well-supported petition. Drawing on our extensive experience and a proven track record of over 32,000 successful cases, our expert team meticulously crafted a compelling petition on the client's behalf.
As a postdoctoral researcher in the field of drug discovery, the client proposed an endeavor to continue research on developing effective and affordable drug and vaccine candidates against deadly infectious diseases. The expert is currently conducting this research at a leading U.S. defense research institute, overseeing the integration of high-throughput screening, in silico modeling, and preclinical testing.
To further emphasize the client's qualifications, we highlighted the following credentials:
The researcher has authored 11 peer-reviewed journal articles (2 of them first-authored), published in top-ranked venues in the field. Moreover, the publications have been cited 64 times. The client has also been invited to conduct a peer review by a respected authority in infectious disease research.
Due to the national importance of this research, the client's work has been supported by prestigious funding sources, including the National Institutes of Health (NIH) and the French National Research Agency (ANR). This funding portfolio underscores both the scientific merit and the broad societal impact of the client's research agenda.
Considering the strength of these accomplishments, we are delighted to share that the NIW petition was approved after 17 months without a Request for Evidence (RFE). It has been an honor to support this talented researcher throughout this journey, and we extend our sincere best wishes for the client's continued success in advancing drug discovery and improving public health outcomes in the United States and beyond.